Nephrotoxic_potential_of_Bence_Jones_proteins__BACKGROUND._The_renal_manifestations_of_diseases_associated_with_the_production_of_monoclonal_light_chains--myeloma_(cast)_nephropathy,_light-chain_deposition_disease,_and_amyloidosis_AL--result_from_the_deposition_of_certain_Bence_Jones_proteins_as_tubular_casts,_basement-membrane_precipitates,_or_fibrils,_respectively._For_unknown_reasons,_the_severity_of_the_renal_manifestations_of_these_diseases_varies_greatly_from_patient_to_patient._We_employed_an_experimental_in_vivo_model_to_determine_the_pathologic_importance_of_various_Bence_Jones_proteins._METHODS._Mice_were_injected_intraperitoneally_with_300_mg_of_Bence_Jones_protein_from_40_patients_with_multiple_myeloma_or_amyloidosis_AL_and_killed_48_hours_later._The_mouse_kidneys_were_examined_by_light_and_electron_microscopy,_and_light-chain_deposits_were_identified_immunohistochemically_with_highly_specific_antihuman_light-chain_antiserum._RESULTS._Of_the_40_different_human_Bence_Jones_proteins_studied,_26_were_deposited_in_the_mouse_kidneys_predominantly_as_tubular_casts,_basement-membrane_precipitates,_or_crystals;_no_light-chain_deposits_were_detected_in_the_kidneys_of_the_mice_that_received_the_other_14_Bence_Jones_proteins._Of_the_18_patients_for_whom_renal_tissue_was_available_for_study,_the_findings_in_14_were_comparable_to_those_in_the_mice._Furthermore,_the_proteins_obtained_from_22_of_the_27_patients_whose_serum_creatinine_concentrations_equaled_or_exceeded_168_mumol_per_liter_(1.9_mg_per_deciliter)_were_deposited_in_the_mouse_kidneys,_whereas_protein_deposition_occurred_after_the_injection_of_proteins_from_only_4_of_the_13_patients_with_serum_creatinine_concentrations_below_168_mumol_per_liter._The_repeated_injection_of_Bence_Jones_proteins_from_two_patients_who_had_amyloidosis_AL_resulted_in_deposition_of_the_protein_in_the_mouse_kidneys_as_amyloid._CONCLUSIONS._Particular_Bence_Jones_proteins_are_primarily_responsible_for_producing_the_distinctive_types_of_protein_deposition_in_renal_tissue_and_the_clinical_manifestations_that_occur_in_patients_with_light-chain-associated_diseases._This_experimental_model_has_potential_value_for_the_identification_of_nephrotoxic_or_amyloidogenic_light_chains.